InsidersTradesSigma
Nykode Therapeutics ASA: management transactions · Norway · Oslo Børs
OSLO:nykode-therapeutics-asaNO·Oslo Børs
Browse the full insider trade history of Nykode Therapeutics ASA, a listed issuer based in Norway. Shares are quoted on NO NO, under the authority of Oslo Børs. The latest transaction was filed on 30 January 2026 — Option grant. Among the most active insiders: Unknown insider (NYKD). All data is free.
52
Insider Decl.
0
Thresholds
€47m
25 ops.
Buy Volume
€23m
9 ops.
Sell Volume
Financial data
3.25 €
Last declaration on 30 January 2026
Declarations52 total
Executives◇Options11Oslo
€367,681600,000 shares@ €0.6128100.0% of flow
OptionXOSL
OSLO:664566·
Executives●Purchase0Oslo
€8,49046,356 shares@ €0.1831
ShareXOSL
OSLO:660428·
Ideal exit: 21 Aug 2026 (T+270)
Executives◇Options0Oslo
OSLO:657010·details not loaded
Executives●Purchase0Oslo
€43,548280,000 shares@ €0.1555
ShareXOSL
OSLO:657002·
Ideal exit: 7 Jul 2026 (T+270)
Executives●Purchase0Oslo
€8,59955,944 shares@ €0.1537
ShareXOSL
OSLO:656985·
Ideal exit: 7 Jul 2026 (T+270)
Executives◇Options0Oslo
OSLO:650976·details not loaded
Executives●Purchase0Oslo
€564,6623,000,000 shares@ €0.1882
ShareXOSL
OSLO:642414·
Ideal exit: 22 Dec 2025 (T+270)
Executives●Purchase0Oslo
€25,290100,000 shares@ €0.2529
ShareXOSL
OSLO:635453·
Ideal exit: 16 Sept 2025 (T+270)
Executives●Purchase0Oslo
€815,9515,000,000 shares@ €0.1632
ShareXOSL
OSLO:631746·
Ideal exit: 5 Aug 2025 (T+270)
Executives●Purchase0Oslo
€24,10350,000 shares@ €0.4821
ShareXOSL
OSLO:625848·
Ideal exit: 18 May 2025 (T+270)
Executives◇Options0Oslo
OSLO:622889·details not loaded
Executives●Purchase0Oslo
€32,20025,000 shares@ €1.288
ShareXOSL
OSLO:614682·
Ideal exit: 21 Dec 2024 (T+270)
Executives●Purchase0Oslo
€26,86620,311 shares@ €1.3227
ShareXOSL
OSLO:614248·
Ideal exit: 16 Dec 2024 (T+270)
Executives●Purchase0Oslo
€12,17910,000 shares@ €1.2179
ShareXOSL
OSLO:613304·
Ideal exit: 8 Dec 2024 (T+270)
Executives●Purchase0Oslo
€32,49925,000 shares@ €1.2999
ShareXOSL
OSLO:613028·
Ideal exit: 3 Dec 2024 (T+270)
Executives●Purchase0Oslo
€48,48740,000 shares@ €1.2122
ShareXOSL
OSLO:612998·
Ideal exit: 3 Dec 2024 (T+270)
Executives●Purchase0Oslo
€29,08120,000 shares@ €1.454
ShareXOSL
OSLO:612556·
Ideal exit: 29 Nov 2024 (T+270)
Executives●Purchase0Oslo
€8,7296,000 shares@ €1.4549
ShareXOSL
OSLO:612321·
Ideal exit: 25 Nov 2024 (T+270)
Executives●Purchase0Oslo
€14,2349,850 shares@ €1.4451
ShareXOSL
OSLO:602645·
Ideal exit: 27 Jul 2024 (T+270)
Executives●Purchase0Oslo
€27,67520,000 shares@ €1.3837
ShareXOSL
OSLO:602442·
Ideal exit: 23 Jul 2024 (T+270)
Executives●Purchase0Oslo
€684,445450,000 shares@ €1.521
ShareXOSL
OSLO:602118·
Ideal exit: 21 Jul 2024 (T+270)
Executives●Purchase0Oslo
€751,870500,000 shares@ €1.5037
ShareXOSL
OSLO:602096·
Ideal exit: 21 Jul 2024 (T+270)
25 of 52 declarations
